William P. Horan

Bristol-Myers Squibb (Germany) — Germany

Medicine · Health Sciences

62h-index14.6kcitations222works5.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Schizophrenia research and treatment(132), Mental Health and Psychiatry(52), Mental Health Research Topics(49), Child and Adolescent Psychosocial and Emotional Development(31), Functional Brain Connectivity Studies(29)

Publications221 total

Improving measurement of attributional style in schizophrenia; A psychometric evaluation of the Ambiguous Intentions Hostility Questionnaire (AIHQ)
UNC Libraries·2025Open Access
The effect of sex on social cognition and functioning in schizophrenia
UNC Libraries·2025Open Access
A Bayesian Network Approach to Social and Nonsocial Cognition in Schizophrenia: Are Some Domains More Fundamental than Others?
UNC Libraries·2025Open Access
Does Xanomeline/Trospium Have Unique Benefits for Cognitive Impairment Associated With Schizophrenia? Response to Tandon
American Journal of Psychiatry·2025
Improving biogenic carbon and land use accounting for construction wood
Resources Conservation and Recycling·2025· 1 citedOpen Access
Methods to address functional unblinding of raters in CNS trials
Translational Psychiatry·2025Open Access
EFFICACY OF KARXT ON NEGATIVE SYMPTOMS IN ACUTE SCHIZOPHRENIA: AN ANALYSIS OF POOLED DATA FROM 3 TRIALS
The International Journal of Neuropsychopharmacology·2025· 1 citedOpen Access
Capturing changes in social functioning and positive affect using ecological momentary assessment during a 12-month trial of xanomeline and trospium chloride in schizophrenia
Schizophrenia Research·2025· 4 citedOpen Access
Response to Commentaries
Schizophrenia Bulletin·2025· 1 citedOpen Access
The Impact of Xanomeline and Trospium Chloride on Cognitive Impairment in Acute Schizophrenia: Replication in Pooled Data From Two Phase 3 Trials
American Journal of Psychiatry·2024· 35 cited
CO159 Challenges on Outcomes Selection Along Early to Late Phase Clinical Trials of Drug Development: Survey to Experts in Neurosciences Drug Development
Value in Health·2024Open Access
Using machine learning to understand social isolation and loneliness in schizophrenia, bipolar disorder, and the community
UNC Libraries·2024Open Access
The potential of muscarinic M1 and M4 receptor activators for the treatment of cognitive impairment associated with schizophrenia
Frontiers in Psychiatry·2024· 19 citedOpen Access
Migration of digital functional capacity assessments from device resident to cloud-based delivery: Development and convergent validity
Schizophrenia Research Cognition·2024· 1 citedOpen Access
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials
Schizophrenia Research·2024· 38 citedOpen Access
Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls
Psychiatry Research·2024· 4 citedOpen Access
412. Efficacy of Karxt on Negative Symptoms in Acute Schizophrenia: A Post Hoc Analysis of Participants With Prominent Negative Symptoms
Biological Psychiatry·2024
414. Understanding the Role of Muscarinic M1 and M4 Receptors in Neural Circuits That Modulate Negative Symptoms of Schizophrenia
Biological Psychiatry·2024· 1 cited
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials
European Neuropsychopharmacology·2024· 4 citedOpen Access
Methods for Neuroscience Drug Development: Guidance on Standardization of the Process for Defining Clinical Outcome Strategies in Clinical Trials
2024Open Access
page 1 of 12Next →

Frequent Co-authors

Michael F. Green(28), Junghee Lee(13), Robert S. Kern(11), Jonathan K. Wynn(11), Jack J. Blanchard(10), Keith H. Nuechterlein(10), Ann M. Kring(8), Mark J. Sergi(6), Kenneth L. Subotnik(6), Raquel E. Gur(5), Catherine A. Sugar(5), Stephen R. Marder(5), Alan Page Fiske(4), Gerhard Hellemann(4), Kimmy S. Kee(4), L. Felice Reddy(4), Steven P. Reise(3), Robert W. Buchanan(3), Joseph Ventura(3), Seth A. Brown(3)